MIRA

MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company based in Baltimore, Maryland, specializing in the advancement of innovative therapies for unmet medical needs. With a robust pipeline of proprietary drug candidates undergoing rigorous clinical trials, MIRA aims to enhance treatment outcomes across various therapeutic areas. The company's strong commitment to research and development, coupled with its potential to disrupt the biopharmaceutical landscape, positions it as an attractive investment opportunity for institutional investors seeking exposure in the dynamic biotech sector.